Outsourced sales development for biotech

Biotech appointment setting: meetings with the scientists who pick the tools

If you sell instruments, reagents, software, bioprocess equipment or outsourced R&D to biotech companies, the person who decides is usually a scientist with a specific experiment or process problem, and the person who pays is someone else. We book meetings with the R&D and process development leaders who own those problems, timed to the funding and program milestones that open budget.

Qualified biotech meetings on your calendar, booked by U.S.-based SDRs under your name.

See If My Market Is Available See Client Results

Ask Ava anything about the information on this page.

The sales floor behind your biotech program

  • $1B+in client revenue generated
  • 100,000+meetings booked a year
  • 2,000clients
  • 17+years on the phones
  • 4.8 / 5on Google, 4.6 on Clutch, 4.64 with the BBB

Abstrakt company figures as of October 2026; ratings as published on Google, Clutch and the BBB, September 2026. See client results.

What we fix

Why biotech pipelines stall, and what changes

  • Scientists ignore generic sales outreach

    Your SDR learns your technology and leads with the experiment or process problem it solves, so the conversation sounds credible from the first call.

  • The user and the buyer are different people

    We reach the scientist who will use it and the leader who funds it, and track both in the same account notes.

  • Evaluations take a long time

    Follow-up stays steady through demos, data reviews and pilot runs, so deals do not stall between steps.

  • Hard to know who just got funded

    The list is built around funding events, program stage and hiring, so outreach reaches companies when budget is opening.

How it works

How we fill your biotech calendar

  1. Build the list

    Biotechs, service providers and research groups that fit your product, sorted by modality, program stage, funding and location, with R&D and process contacts named.

  2. Run the outreach

    A U.S.-based SDR team works phone, email and LinkedIn under your company name, using accurate technical messaging that stays within your approved claims.

  3. Book qualified meetings

    Every meeting is with the right company, the right contact and a timing reason such as a funding round, a stage change or a new lab.

  4. Nurture the rest

    Companies not ready to evaluate stay in a follow-up cadence until the next milestone opens budget.

Every meeting clears three checks before it reaches you

  • Right companyAn account that fits the work you want.
  • Right contactSomeone who signs or shapes the decision.
  • Right timingA stated need or a reason to talk now.

Then it is graded on our 25-point 5 Star Scorecard. What counts as a qualified appointment.

We take one biotech client per territory

If yours is open, a strategist can walk you through the target list, the outreach and the meeting number on one call.

Check my territory →Call (314) 338-8865
Where the pipeline comes from

The accounts a biotech program calls

  • Venture-backed discovery-stage biotechs

    Small teams building out labs after a funding round, choosing instruments, assay platforms and outsourced partners for the first time.

  • Clinical-stage biotechs moving toward manufacturing

    Programs heading into later trials need process development, scale-up, analytics and a CDMO, and the decisions get made by a few people.

  • Cell and gene therapy developers

    Specialized manufacturing, vector production, analytics and cold chain needs that standard suppliers often do not cover well.

  • CROs and CDMOs serving biotech

    Service providers buy equipment, software and consumables at volume and add capacity as they win new programs.

  • Industrial and synthetic biology companies

    Strain engineering, fermentation and scale-up work that needs bioreactors, screening tools and process analytics.

  • University spinouts and incubator tenants

    Early companies in shared lab space with grant or seed funding, often choosing their first core platforms.

Who decides

The people behind a biotech buying decision

Head of R&D or principal scientist
Controls
Which platforms, assays and tools the lab adopts and the technical evaluation behind them.

How to open: Ask what is slowing down the current program, such as throughput, data quality or assay development time.

Process development or bioprocess lead
Controls
Scale-up, upstream and downstream methods, and the equipment and partners used to get there.

How to open: Ask where they are in scale-up and what they plan to bring in-house versus send to a CDMO.

CSO, CTO or founder
Controls
Budget, partnerships and the final call at smaller companies.

How to open: Lead with the program milestone they are trying to hit and what stands in the way, not with features.

Lab manager or operations lead
Controls
Purchasing logistics, vendor setup, installation and lab space.

How to open: Use them to learn what equipment is coming and who is running the evaluation, then reach the scientist who decides.

Reasons to call

What opens a biotech account

  • A new funding round

    Fresh capital is spent on headcount, lab buildout and outsourced work. The weeks after an announcement are when tool and service choices get made.

  • A program moving to the next stage

    Going from discovery to IND-enabling work or from early to late trials changes what the company needs to buy and who it partners with.

  • New lab space or a move

    Buildouts mean new instruments, informatics and services chosen in a short window.

  • Key hires in R&D or process development

    A new head of a function often brings preferred tools and reviews existing vendors.

  • A partner or CDMO falling short

    Missed timelines or quality issues at an outsourcing partner push teams to look for a second source.

Our terms

Why companies hand us the phones

  • Program commitments

    Program expectations and commitments are defined in your agreement. Before launch we agree on what a qualified meeting is, who we call and how results are reported.

  • Exclusive to your territory

    One biotech client per territory. We will not run the same program for your direct competitor in your territory.

  • A U.S.-based SDR team

    Your SDR works under your company's name from our St. Louis campus, home to 500+ U.S.-based team members.

  • Every meeting graded

    Every booked meeting is graded on a 25-point scorecard before it reaches your calendar. Grade a sample call yourself.

Straight answers

What we hear before a program starts

  • “Our best work comes from referrals.”

    Keep every one of them. Referrals close well, but they do not arrive on a schedule and they never reach the accounts that have not heard of you. Outbound adds a source you control, under your name, so a slow referral quarter does not turn into a slow year.

  • “Our buyers do not answer cold calls.”

    Most do not, the first time. That is why your SDR works phone, email and LinkedIn together and keeps going after the first no. Meetings come from persistence and a specific reason to talk, not a clever script.

  • “We tried an appointment setter and the meetings were junk.”

    Then nobody pinned down what a meeting was. Before launch we agree on the definition with you: right company, right contact, right timing. Every meeting is graded on our 25-point 5 Star Scorecard before it reaches your calendar.

  • “We could hire our own SDR.”

    You can. Then the recruiting, training, data, dialer and management are yours, and a hire that does not work out costs months before you know it. With us the SDR, the data and the management come with the program. Program expectations and commitments are defined in your agreement.

Customer results

Client results, published only with approval

We publish a client result after the client approves it and the figure has a period. There is no approved biotech story yet, so we are not showing one. The Success library has approved stories from other industries, and a strategist can introduce you to a current client on request.

Calculate my opportunity

What a biotech pipeline takes, in your numbers

Set a monthly meeting goal and your own conversion rates. Green tags are Abstrakt history, yellow is a broader cross-industry benchmark, gray tags are your inputs. Value appears once you enter your own average.

Your inputs

125 is the cross-industry average from our sales center, not a biotech rate. Change it if you know yours.

An appointment is not a proposal. 25% is only a starting example, not Abstrakt data: use your own experience.

20% is a starting example, not Abstrakt data. Use your own close rate.

What a new customer is worth to you in the first year.

Illustrative math from your inputs. It updates as you type.

  • 1,000dials a month
  • 48dials every working day
  • 2proposals a month
  • 0.4wins a month, on average
  • 4.8wins from 12 months at this pace
  • 96meetings over 12 months

  • Enter your average first-year deal value to see contract value. We do not fill in a number for you.

How this works: appointments x dials per appointment = outreach, spread over 21 working days. Appointments x your proposal rate x win rate = wins. Wins x your value = contract value: what signed work is worth, not revenue recognized. Fractions are monthly averages. Not a forecast, a quote or a promise.

Book my strategy call → (314) 338-8865
Decide with the facts

See how Abstrakt works for biotech

Abstrakt at a Glance answers the five questions buyers ask before they sign: how it works, what clients got, what calls sound like, what reviewers say and what it costs.

  • Program commitments

    Program expectations and commitments are defined in your agreement. Before launch we agree on what a qualified biotech meeting is, who we call and how results are reported.

  • Exclusive to your territory

    One client per trade per territory: we will not run the same program for your direct competitor in your territory.

  • Pricing

    Outbound BDR programs: starting at $5,000 per month. See what a program includes.

Beyond the calls

What your biotech buyers see after the first conversation

Our SDRs open the door. Our creative and inbound teams make sure what a buyer finds next, your website and the material your reps send, closes the gap.

Sales collateral Sell sheets, case studies and decks for heads of r&d The one-pager in the follow-up email, the case study they forward upstairs, the deck for the first meeting. See the collateral portfolio →
Websites and inbound A website that turns biotech searches into calls Inbound SDR builds the site, content and search presence that turn interest into conversations your team can work. Shown: Ironwatch Security. See Inbound SDR →
Questions

Biotech appointment setting, answered

What kinds of companies does this fit?+

Companies selling instruments, reagents and consumables, lab software and informatics, bioprocess and automation equipment, and outsourced R&D or manufacturing services to biotech companies.

How is this different from your life science program?+

This program targets the scientists and process teams at biotech companies who choose research tools and partners. Our life science program targets lab operations, quality and facility buyers across pharma, medical devices and clinical labs.

How do you speak to technical audiences without overselling?+

Your SDR is trained on your technology and approved claims, and leads with the scientific problem you solve. No claims go out that your team has not signed off.

Will you work for a competing company?+

No. We run one program per product category in each market, so a direct competitor will not get the same accounts or messaging.

Our four solutions

Four Solutions. One Team.

Individually powerful. Better together. Our four solutions work together to find your buyers, book meetings with them and help your team close more of them.

All three together: Get Outbound BDR, Inbound SDR and Brand Boost together, starting at $6,500 per month ($5,000 + $1,000 + $500 = $6,500). Enterprise SDR/BDR is custom.Build my program

Your Sales Calendar, Handled

Stop riding the feast-or-famine cycle. We fill your calendar with qualified meetings while your team does what it does best, winning and delivering the work.

Book my strategy callSee How It Works (314) 338-8865
Sales Talk newsletter

Get Sales Talk in your inbox

New playbooks, benchmarks and guides from our sales floor, for owners and sales leaders who sell to businesses. One email a month. See past issues.

Your email and the details you choose to add, nothing else. We never sell or share your address, and every issue has a one-click unsubscribe. Privacy Policy.

Book my strategy callCall (314) 338-8865